The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study - Wongsakorn Luangphiphat; Pinidphon Prombutara; Praewpannarai Jamjuree; Chantanapa Chantarangkul; Porntipha Vitheejongjaroen; Chantaluck Muennarong; Krittapat Fukfon; Manasvin Onwan; Malai Taweechotipatr (PLoS ONE, 2025)